Home | Consumers | Health Professionals | Regulatory | Other | Hot Topics | Search
Website: December 2010
Prescriber Update 2010; 31(4):33
Medication errors involving Humalog insulin products continue to occur in New Zealand hospitals.
Three Humalog products are currently available and funded in New Zealand: Humalog, Humalog Mix 25, and Humalog Mix 50. Errors continue to occur during the prescribing, dispensing and administration of these products.
There is potential for harm if a patient receives the wrong Humalog product, for example, the rapid acting Humalog when a combination rapid/ intermediate acting Humalog Mix product is intended.
The following actions are recommended to prevent these errors occurring:
The manufacturer of Humalog products has made changes to the product labels to help better distinguish between the different products. These changes followed similar issues experienced in Europe.